Sort
25,944 grants matching “neurodegeneration”
Age-dependent activation of microglia inflammatory state and its epigenetic modulation
$2,994,272Anne Schaefer · Icahn School Of Medicine At Mount Sinai · RF1 · FY2020 · AG
Indiana Alzheimer's Disease Research Center
$2,988,197Andrew J Saykin · Indiana University Indianapolis · P30 · FY2023 · AG
Extracellular vesicle transport of brain-derived proteins to the blood in Alzheimer disease
$2,981,849Min Shi · University Of Washington · RF1 · FY2020 · AG
Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System
$2,977,025Marcie A Glicksman · Enclear Therapies, Inc. · R44 · FY2025 · NS
Alzheimer's Disease Research Center
$2,969,448Douglas R Galasko · University Of California, San Diego · P50 · FY2010 · AG
Function and Regulation of ALDH1A1-positive Nigrostriatal Dopaminergic Neurons in Motor Performance and Parkinson's disease
$2,963,281Huaibin Cai · National Institute On Aging · ZIA · FY2025 · AG
Escitalopram for Agitation in Alzheimer Disease
$2,959,649Constantine G Lyketsos · Johns Hopkins University · R01 · FY2022 · AG
Deciphering the role of CD44 astrocytes in Alzheimer's disease
$2,957,210Osama Al Dalahmah · Columbia University Health Sciences · RF1 · FY2025 · AG
Mitochondrial stress responses in neurodegeneration
$2,952,417Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
South Texas Alzheimer's Disease Center
$2,946,508Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2025 · AG
South Texas Alzheimer's Disease Center
$2,945,927Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2024 · AG
South Texas Alzheimer's Disease Center
$2,945,345Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2023 · AG
South Texas Alzheimer's Disease Center
$2,944,764Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2022 · AG
Proteinopathies of the Aging Central Nervous System
$2,943,317Lennart Mucke · J. David Gladstone Institutes · P01 · FY2008 · AG
Indiana Alzheimer's Disease Research Center
$2,942,747Andrew J Saykin · Indiana University Indianapolis · P30 · FY2024 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,939,543David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Pharmaceutical Research Center
$2,932,203Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2009 · RR
Alzheimer's Disease Research Center
$2,930,762Douglas R Galasko · University Of California, San Diego · P50 · FY2011 · AG
Protein Trafficking In The Endosomal-Lysosomal System
$2,930,227Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients
$2,926,978Hans Joerg Moebius · Athira Pharma, Inc. · R01 · FY2022 · AG
Characterizing WDR23 in Alzheimer's disease pathology
$2,924,025Sean P. Curran · University Of Southern California · RF1 · FY2019 · AG
Alzheimer's Disease Research Center
$2,922,029Douglas R Galasko · University Of California, San Diego · P50 · FY2012 · AG
UCSD Alzheimer's Disease Research Center P50
$2,919,722Douglas R Galasko · University Of California, San Diego · P50 · FY2015 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,917,540David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,916,751Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES